Kd: how tightly does it hold?
Recall that a drug binds and releases its target over and over. The dissociation constant Kd puts a single number on that balance: it is the drug concentration at which exactly half the targets are occupied at any moment — its receptor occupancy reaches 50%. The lower the Kd, the *less* drug you need to fill half the targets, so a low Kd means a tight grip. This tightness of binding is what pharmacologists call affinity.
Kd = 1 nM -> half the targets filled at 1 nM -> TIGHT grip, high affinity Kd = 1 uM -> need 1000x more drug for the same -> loose grip, low affinity Rule of thumb: lower Kd = higher affinity = fewer molecules needed.
Ki: how strongly does a blocker compete?
Kd describes a drug binding on its own. But many drugs are blockers that fight an active drug for the same site — competitive antagonism. For these, we use the inhibition constant Ki: the concentration of blocker that effectively halves the binding of the other molecule. Just like Kd, a lower Ki means a stronger, tighter-binding competitor. Ki is essentially the affinity of a blocker measured in a competition.
Why two constants instead of one? Because they answer different questions. Kd asks *how tightly does this molecule bind on its own*; Ki asks *how well does this molecule shove a rival off the same site*. When you read a drug's data sheet, a small Kd tells you it grabs its target, and a small Ki tells you it makes a formidable competitive blocker.
When the body changes the count
Binding constants assume a fixed number of receptors, but the body does not hold still. Stimulate a receptor relentlessly and the cell makes fewer of them — receptor down-regulation. Block or starve a receptor for a long time and the cell makes more — receptor up-regulation. The cell is forever trying to keep its sensitivity in a comfortable middle.
These slow changes explain two things patients feel directly. Down-regulation is one cause of drug tolerance — the same dose works less well over weeks — and its very fast cousin is tachyphylaxis, a drop in response after just a few rapid doses. Up-regulation explains *rebound*: stop a long-term blocker suddenly and the now-too-many receptors get flooded by the body's own ligand, sometimes dangerously. This is exactly why beta-blockers and some other drugs must be tapered, never stopped abruptly.